In combining the precision of the twiist insulin delivery system with the unmatched longevity of Eversense 365, Sequel and Senseonics are enhancing diabetes management by offering more tools to manage ...

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. Its GAAP loss of $0.01 per share ...

Insulin is a generic prescription drug approved for blood sugar management in certain animals, including cats. Learn how to save money on your cat's prescription.

Insulin is a generic prescription drug approved for blood sugar management in certain animals, including dogs. Learn how to ...

Lifestyle changes and awareness are extremely important to combat diabetes, says Dr Ali Mohammad Aldibbiat. The renowned expert in diabetes management and research, shares his insights on the alarming ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results , with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716 ...

Stephanie Jepchumba Ruto draws attention at a fundraiser, where she donates KSh 3 million for children's welfare, highlighting her commitment to youth development.

No. 1 / 2026Zealand Pharma Announces Financial Results for the Full Year 20252025 marked a quantum leap for Zealand ...

Company announcement - No. 1 / 2026 Zealand Pharma Announces Financial Results for the Full Year 2025 2025 marked a quantum leap for Zealand Pharma, with a transformative partnership for petrelintide, ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its ...

Regan Roat, MD, PhD, is an endocrinologist specializing in Type 1 and 2 diabetes, pregnancy care, gestational diabetes, and preconception counseling.

Sequel Med Tech and (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration.